H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas

Pediatric high-grade gliomas (pHGGs) are diffuse and highly aggressive CNS tumors which remain incurable, with a 5-year overall survival of less than 20%. Within glioma, mutations in the genes encoding the histones H3.1 and H3.3 have been discovered to be age-restricted and specific of pHGGs. This w...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Fabiani, Maria B., Haase, Santiago, Banerjee, Kaushik, McClellan, Brandon, Zhu, Ziwen, Mujeeb, Anzar, Li, Yingxiang, Yu, Jin, Kadiyala, Padma, Taher, Ayman, Núñez, Felipe J., Alghamri, Mahmoud S., Comba, Andrea, Mendez, Flor M., Nicola Candia, Alejandro J., Salazar, Brittany, Koschmann, Carl, Nunez, Fernando M., Edwards, Marta, Qin, Tingting, Sartor, Maureen A., Lowenstein, Pedro R., Castro, Maria G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312611/
https://www.ncbi.nlm.nih.gov/pubmed/37398299
http://dx.doi.org/10.1101/2023.06.13.544658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312611/
https://www.ncbi.nlm.nih.gov/pubmed/37398299
http://dx.doi.org/10.1101/2023.06.13.544658

Ejemplares similares